France Pharmaceuticals Market Size, Share & Trends Analysis Report By Molecule Type, By Product, By Type, By Disease, By Formulation, By Age Group, By Route Of Administration, By End Market, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product Type
                        1.2.2. Distribution Channels
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Italy
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Distribution Channels
                    2.3. Competitive Insights
Chapter 3. Pharmaceutical Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing healthcare spending by the government
                            3.2.1.2. Improving affordability driven by rising per capita income
                            3.2.1.3. Increasing awareness about healthcare among the population
                            3.2.1.4. Increasing access to innovative and modern medicines
                            3.2.1.5. Demographic and lifestyle changes leading to rising prevalence of chronic diseases
                            3.2.1.6. Rising chronic diseases and geriatric population
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. COVID-19 pandemic
                            3.2.2.2. Intensification of competition from generic and biosimilar drugs
                            3.2.2.3. Increasing price-sensitivity of customers for non-reimbursed drugs
                            3.2.2.4. Increasing Barriers to Market Access and decreasing R&D productivity of pharma companies
                    3.3. France Pharmaceutical Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. France Pharmaceutical Market Product Estimates & Trend Analysis
                    4.1. France Pharmaceutical Market Product Dashboard
                    4.2. France Pharmaceutical Market Product Movement Analysis
                    4.3. France Pharmaceutical Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.4. Biologics & Biosimilars
                        4.4.1. Biologics & Biosimilars Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.2. Monoclonal Antibodies
                            4.4.2.1. Monoclonal Antibodies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.3. Vaccines
                            4.4.3.1. Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.4. Cell & Gene Therapy
                            4.4.4.1. Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.5. Others
                            4.4.5.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                    4.5. Conventional Drugs (Small Molecules)
                        4.5.1. Conventional Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. France Pharmaceutical Market: Product Estimates & Trend Analysis
                    5.1. France Pharmaceutical Market Product Dashboard
                    5.2. France Pharmaceutical Market Product Movement Analysis
                    5.3. France Pharmaceutical Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.4. Branded
                        5.4.1. Branded Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.5. Generic
                        5.5.1. Generic Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Pharmaceutical Market: Type Estimates & Trend Analysis
                    6.1. Pharmaceutical Market: Type Movement Analysis
                    6.2. Prescription
                        6.2.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.3 OTC
                        6.3.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Pharmaceutical Market: Diseases Outlook Estimates & Trend Analysis
                    7.1. Pharmaceutical Market: Diseases Outlook Movement Analysis
                    7.2. Cardiovascular diseases
                        7.2.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.3. Cancer
                        7.3.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.4. Diabetes
                        7.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.5. Infectious diseases
                        7.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.6. Neurological disorders
                        7.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.7. Respiratory diseases
                        7.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.8. Autoimmune diseases
                        7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.9. Mental health disorders
                        7.9.1. Mental Health Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.10. Gastrointestinal disorders
                        7.10.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.11. Women’s Health Diseases
                        7.11.1. Women’s Health Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.12. Genetic and Rare genetic diseases
                        7.12.1. Genetic and Rare Genetic Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.13. Dermatological conditions
                        7.13.1. Dermatological Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.14. Obesity
                        7.14.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.15. Renal diseases
                        7.15.1. Renal Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.17. Liver conditions
                        7.17.1. Liver Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.17. Hematological disorders
                        7.17.1. Hematological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.18. Eye conditions
                        7.18.1. Eye Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.19. Infertility conditions
                        7.19.1. Infertility Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.20. Endocrine disorders
                        7.20.1. Endocrine Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.21. Allergies
                        7.21.1. Allergies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    7.22. Others
                        7.22.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Pharmaceutical Market: Route of Administration Estimates & Trend Analysis
                    8.1. Pharmaceutical Market: Route of Administration Movement Analysis
                    8.2. Oral
                        8.2.1. Oral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.3. Topical
                        8.3.1. Topical Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.4. Parenteral
                        8.4.1. Parenteral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                            8.4.1.1. Intravenous
                            8.4.1.2. Intramuscular
                    8.5. Inhalations
                        8.5.1. Inhalations Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    8.6. Other
                        8.6.1. Other Routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Pharmaceutical Market: Formulation Estimates & Trend Analysis
                    9.1. Pharmaceutical Market: Formulation Movement Analysis
                    9.2. Tablets
                        9.2.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.3. Capsules
                        9.3.1. Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.4. Injectable
                        9.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.5. Sprays
                        9.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.6. Suspensions
                        9.6.1. Suspensions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.7. Powders
                        9.7.1. Powders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    9.8. Other Formulations
                        9.8.1. Other Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 10. Pharmaceutical Market: Age Group Estimates & Trend Analysis
                    10.1. Pharmaceutical Market: Age Group Movement Analysis
                    10.2. Children & Adolescents
                        10.2.1. Children & Adolescents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    10.3. Adults
                        10.3.1. Adults Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    10.4. Geriatric
                        10.4.1. Geriatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 11. Pharmaceutical Market: End Market Estimates & Trend Analysis
                    11.1. Pharmaceutical Market: End Market Movement Analysis
                    11.2. Hospitals
                        11.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    11.3. Clinics
                        11.3.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    11.4. Others
                        11.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 12. Competitive Landscape
                    12.1. Recent Developments & Impact Analysis, By Key Market Participants
                    12.2. Company/Competition Categorization
                    12.3. Vendor Landscape
                        12.3.1. List of key distributors and channel partners
                        12.3.2. Key customers
                        12.3.3. Key company market share analysis, 2023
                        12.3.4. Abbott
                            12.3.4.1. Company overview
                            12.3.4.2. Financial performance
                            12.3.4.3. Product benchmarking
                            12.3.4.4. Strategic initiatives
                        12.3.5. Merck &Co.,
                            12.3.5.1. Company overview
                            12.3.5.2. Financial performance
                            12.3.5.3. Product benchmarking
                            12.3.5.4. Strategic initiatives
                        12.3.6. Astrazeneca
                            12.3.6.1. Company overview
                            12.3.6.2. Financial performance
                            12.3.6.3. Product benchmarking
                            12.3.6.4. Strategic initiatives
                        12.3.7. Abbvie
                            12.3.7.1. Company overview
                            12.3.7.2. Financial performance
                            12.3.7.3. Product benchmarking
                            12.3.7.4. Strategic initiatives
                        12.3.8. Gilead Sciences
                            12.3.8.1. Company overview
                            12.3.8.2. Financial performance
                            12.3.8.3. Product benchmarking
                            12.3.8.4. Strategic initiatives
                        12.3.9. Alexion Pharmaceuticals
                            12.3.9.1. Company overview
                            12.3.9.2. Financial performance
                            12.3.9.3. Product benchmarking
                            12.3.9.4. Strategic initiatives
                        12.3.10. Novartis
                            12.3.10.1. Company overview
                            12.3.10.2. Financial performance
                            12.3.10.3. Product benchmarking
                            12.3.10.4. Strategic initiatives
                        12.3.11. Eli Lily Company
                            12.3.11.1. Company overview
                            12.3.11.2. Financial performance
                            12.3.11.3. Product benchmarking
                            12.3.11.4. Strategic initiatives
                        12.3.12. Novo Nordisk
                            12.3.12.1. Company overview
                            12.3.12.2. Financial performance
                            12.3.12.3. Product benchmarking
                            12.3.12.4. Strategic initiatives
                        12.3.13. Sanofi
                            12.3.13.1. Company overview
                            12.3.13.2. Financial performance
                            12.3.13.3. Product benchmarking
                            12.3.13.4. Strategic initiatives
                        12.3.14. Eisai
                            12.3.14.1. Company overview
                            12.3.14.2. Financial performance
                            12.3.14.3. Product benchmarking
                            12.3.14.4. Strategic initiatives
                        12.3.15. Curium
                            12.3.15.1. Company overview
                            12.3.15.2. Financial performance
                            12.3.15.3. Product benchmarking
                            12.3.15.4. Strategic initiatives
                        12.3.16. Alfasigma
                            12.3.16.1. Company overview
                            12.3.16.2. Financial performance
                            12.3.16.3. Product benchmarking
                            12.3.16.4. Strategic initiatives
                        12.3.17. BAYER Healthcare SAS
                            12.3.17.1. Company overview
                            12.3.17.2. Financial performance
                            12.3.17.3. Product benchmarking
                            12.3.17.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 France Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 3 France Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 4 Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 5 Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 6 France Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 7 France Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 8 France Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 9 France Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Pharmaceutical Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Pharmaceutical market: Molecule type outlook and key takeaways Conventional dr
Fig. 15 Pharmaceutical market: Product outlook and key takeaways
Fig. 16 Pharmaceutical market: Product movement analysis & market share 2022 & 2030
Fig. 17 Branded pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 18 Generics pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 19 Pharmaceutical market: Type outlook and key takeaways
Fig. 20 Pharmaceutical market: Type movement analysis & market share 2022 & 2030
Fig. 21 Prescription pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 22 OTC pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 23 Pharmaceutical market: Disease outlook and key takeaways
Fig. 24 Pharmaceutical market: Disease movement
Fig. 25 Pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 26 Pharmaceutical market: Formulation outlook and key takeaways
Fig. 27 Pharmaceutical market: Formulation movement analysis & market share 2022 & 2030
Fig. 28 Tablets pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 29 Capsules pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 30 Injectables pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 31 Sprays pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 32 Suspensions pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 33 Powders pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 34 Others formulation pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 35 Pharmaceutical market: Age group outlook and key takeaways
Fig. 36 Pharmaceutical market: Age group movement analysis & market share 2022 & 2030
Fig. 37 Children & Adolescents pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 38 Adults pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 39 Geriatric pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 40 Pharmaceutical market: End outlook and key takeaways